Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration

Kento Tateishi1, Eishi Ashihara, Naofumi Takehara

  • 1Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital, Kyoto 606-8507, Japan.

Insights

Stem cell antigen-1 (Sca-1) is crucial for cardiac stem cell (CSC) proliferation and survival. Sca-1 promotes CSC engraftment and indirectly supports cardiovascular differentiation post-transplantation.

Area of Science:

  • Cardiovascular Biology
  • Stem Cell Research

Background:

  • Adult mammalian hearts contain cardiac stem cells (CSCs) capable of generating cardiomyocytes.
  • Definitive CSC surface markers and growth regulators remain largely unknown.

Purpose of the Study:

  • To identify specific surface markers for CSCs.
  • To investigate molecular mechanisms governing CSC proliferation and survival.

Main Methods:

  • Single-cell deposition analysis to isolate individual CSCs from adult murine hearts.
  • Utilized a TERT promoter-driven GFP reporter transgene.
  • Investigated the role of Sca-1 via transcript knockdown.

Main Results:

  • Clonally expanded CSCs express Sca-1, exhibit ES and mesenchymal cell-like traits, and associate with telomerase reverse transcriptase (TERT).
  • TERT(GFP)-positive cardiac fractions were enriched for Sca-1-expressing cells.
  • Sca-1 knockdown impaired CSC expansion, induced apoptosis via Akt inactivation, and hindered post-transplantation survival and function.

Conclusions:

  • Sca-1 is essential for CSC proliferation and survival, facilitating early engraftment.
  • Sca-1 indirectly promotes late cardiovascular differentiation through paracrine signaling, enhancing neoangiogenesis and reducing cardiac apoptosis.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...